Foghorn Therapeutics FHTX
NASDAQ FHTX
$3.52 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Foghorn Therapeutics (FHTX) Current Leases (2021)

Updated

Foghorn Therapeutics (FHTX) reported Current Leases of $106,000 for Q2 2021, up 1.0% from the prior quarter.

Analysis

Foghorn Therapeutics (FHTX) Current Leases (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Foghorn Therapeutics 206.67 Mn -119.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 106,000.00
Mar 31, 2021 105,000.00
API Access

Foghorn Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=FHTX&period=max&api_key=YOUR_API_KEY